Parkinson's Neurostimulation trials

Precision Sensorimotor Neurorehabilitation Through Personalized Stimulation Loops

RecruitingNCT06608875Phase: NAStarted 2024-05-16

Summary

Parkinson's disease (PD) is a neurodegenerative disease that affects about 1% of the elderly population and accounts for substantial disability and health care costs. Disability is largely driven by

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
None

Locations

University Hospital ZurichZurich, Canton of Zurich, Switzerland

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT06608875